Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |